jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Alkaline Phosphatase

Stomach
image

Report in 4Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Enzyme from liver and bones; elevated in bile obstruction, bone disease, or metastases.

₹49₹210

77% OFF

Alkaline Phosphatase - Comprehensive Medical Test Guide

  • Why is it done?
    • Alkaline phosphatase is an enzyme found in blood that is produced primarily by the liver, bones, kidneys, and intestines. This test measures the level of ALP enzyme to assess liver function, bone metabolism, and biliary duct integrity.
    • Detecting liver disease and biliary obstruction (cirrhosis, hepatitis, cholestasis, bile duct obstruction)
    • Assessing bone disorders and metabolic bone disease (osteoporosis, Paget's disease, rickets, bone metastases)
    • Evaluating growth and development in children (growth spurts increase ALP naturally)
    • Monitoring effectiveness of cancer treatment and detecting cancer spread to bone
    • Part of routine liver function tests during annual physical examinations
    • Investigating symptoms such as jaundice, abdominal pain, or unexplained bone pain
    • Monitoring patients on medications that may affect liver function
  • Normal Range
    • Adults (30-120 years): 30-120 IU/L (International Units per Liter) or 0.5-2.0 µkat/L (microkatal per liter)
    • Children and adolescents: 44-147 IU/L (higher due to active bone growth; ranges vary with age and gender)
    • Pregnant women: May be slightly elevated due to placental production
    • Normal range may vary slightly by laboratory; reference ranges should be consulted from your specific testing facility
    • Result Interpretation:
    • Normal/Negative: Within reference range indicates normal liver function, bone metabolism, and no evidence of biliary obstruction
    • Elevated/High: Above the upper limit of normal suggests liver disease, bone disorders, or biliary tract obstruction
    • Low: Below the lower limit of normal may indicate hypophosphatasia, malnutrition, or hypothyroidism (clinically less significant than elevated levels)
  • Interpretation
    • Moderately Elevated (1.5-3 times upper limit of normal):
      • Hepatitis, fatty liver disease, cirrhosis, or bone growth acceleration
    • Markedly Elevated (>3-4 times upper limit of normal):
      • Biliary obstruction, complete cholestasis, liver cancer, Paget's disease, or bone metastases from cancer
    • Factors Affecting Results:
      • Age: Children and adolescents have naturally higher levels; increases again in elderly patients
      • Gender: May be slightly higher in males; women on estrogen therapy may have lower levels
      • Pregnancy: ALP increases progressively, especially in third trimester
      • Medications: Oral contraceptives, antibiotics, NSAIDs, statins, and immunosuppressants may elevate levels
      • Bone isoenzyme elevation in patients with healing fractures, osteoporosis treatment, or intense physical exercise
      • Recent meal consumption or certain foods may slightly affect results
    • Clinical Significance of Result Patterns:
      • Isolated elevation with normal bilirubin and transaminases: May indicate bone disease or benign elevation
      • Elevation with elevated bilirubin: Suggests biliary tract obstruction or cholestasis
      • Elevation with elevated transaminases (AST/ALT): Indicates hepatocellular injury or liver disease
      • Disproportionate elevation compared to other liver enzymes: Suggests bone source (Paget's disease, metastatic bone disease)
  • Associated Organs
    • Primary Organ Systems Involved:
      • Liver and Biliary System: Primary source in adults; elevated in hepatitis, cirrhosis, cholestasis, biliary obstruction
      • Skeletal System: Major source in children and patients with bone disease; elevated in rickets, osteoporosis, Paget's disease, metastatic bone cancer
      • Intestinal tract: Contributes to baseline serum ALP levels
      • Kidneys and Placenta: Minor contributors; placental ALP increases significantly during pregnancy
    • Common Diseases Associated with Abnormal Results:
      • Liver Diseases:
      • Acute and chronic hepatitis (viral, autoimmune, alcoholic)
      • Cirrhosis and liver fibrosis
      • Fatty liver disease (NAFLD, AFLD)
      • Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)
      • Liver cancer and hepatocellular carcinoma
      • Biliary Disorders:
      • Extrahepatic and intrahepatic cholestasis
      • Gallstones and bile duct stones
      • Pancreatic cancer causing bile duct obstruction
      • Bone and Metabolic Disorders:
      • Paget's disease of bone (can cause levels 10-20 times normal)
      • Rickets (vitamin D deficiency or resistant rickets)
      • Osteoporosis and rapid bone loss
      • Bone metastases from primary cancers (breast, prostate, lung)
      • Hyperparathyroidism and bone remodeling disorders
      • Hypophosphatasia (genetic disorder causing low ALP)
      • Other Conditions:
      • Infections (mononucleosis, tuberculosis, bacterial infections)
      • Thyroid disorders (hyperthyroidism and hypothyroidism)
      • Inflammatory bowel disease (Crohn's disease, ulcerative colitis)
    • Potential Complications Associated with Abnormal Results:
      • Elevated ALP with biliary obstruction may lead to secondary biliary cirrhosis if not treated
      • Bone metastases indicated by elevated ALP may cause pathologic fractures or spinal cord compression
      • Paget's disease with high ALP increases risk of bone deformities, fractures, and osteosarcoma
      • Severe rickets may cause developmental delays, growth retardation, and skeletal deformities
      • Untreated liver disease with persistent ALP elevation may progress to end-stage liver disease
  • Follow-up Tests
    • Liver-Specific Follow-up Tests:
      • Liver function panel: AST (aspartate aminotransferase), ALT (alanine aminotransferase), GGT (gamma-glutamyl transferase), 5'-nucleotidase to identify source of elevation
      • Bilirubin (total and direct) to assess for cholestasis or biliary obstruction
      • Albumin and prothrombin time (PT/INR) to assess synthetic liver function
      • ALP isoenzyme testing to differentiate liver versus bone source
      • Hepatitis serology (A, B, C) if viral hepatitis suspected
      • Autoimmune markers if autoimmune liver disease considered
    • Imaging Studies if Biliary Obstruction Suspected:
      • Ultrasound of abdomen to visualize biliary tree and pancreas
      • CT scan or MRI of abdomen for detailed assessment
      • MRCP (magnetic resonance cholangiopancreatography) for bile duct visualization
      • ERCP (endoscopic retrograde cholangiopancreatography) for therapeutic intervention if obstruction confirmed
    • Bone-Specific Follow-up Tests:
      • Calcium, phosphate, and magnesium levels to assess bone metabolism
      • Vitamin D (25-hydroxyvitamin D) to evaluate for deficiency
      • Parathyroid hormone (PTH) if hyperparathyroidism suspected
      • Bone markers: P1NP (procollagen type 1 N-terminal propeptide), CTX (C-terminal telopeptide)
      • DEXA scan (bone density scan) to assess for osteoporosis
      • X-rays, CT, or bone scan if Paget's disease or bone metastases suspected
    • Monitoring Frequency for Ongoing Conditions:
      • Chronic liver disease: Every 3-6 months to monitor disease progression
      • Treatment of cancer with bone metastases: Every 3 months to assess treatment response
      • Paget's disease under bisphosphonate therapy: Every 6 months until stable, then annually
      • Osteoporosis management: Every 6-12 months depending on treatment
      • Post-fracture healing: Every 2-4 weeks until ALP returns to normal baseline
    • Related Complementary Tests:
      • Liver biopsy if advanced fibrosis or cirrhosis evaluation needed
      • FibroScan (transient elastography) to assess liver fibrosis
      • Tumor markers (AFP for hepatocellular carcinoma) if malignancy suspected
      • Bone marrow biopsy in rare cases where hematologic malignancy suspected
  • Fasting Required?
    • No fasting is required for the alkaline phosphatase test.
    • Alkaline phosphatase levels are not significantly affected by food intake or fasting status.
    • However, if the ALP test is part of a comprehensive metabolic panel (CMP) or liver function panel that includes other tests, fasting may be required for those additional tests (such as glucose and lipids).
    • Patient Preparation Instructions:
      • No special preparation needed: Can eat and drink normally before the test
      • Medications: Continue taking all regular medications unless otherwise instructed by your healthcare provider
      • Specific medications to note: Inform your doctor if taking antibiotics, NSAIDs, phenothiazines, or other medications known to affect ALP levels, as this may help interpret results
      • Hydration: Can drink water freely; staying hydrated helps with blood draw
      • Clothing: Wear loose-fitting sleeves to facilitate blood draw from the arm
      • Activity: No special activity restrictions before or after the test
      • Stress: Avoid excessive physical exercise or stress immediately before test if possible, as some studies suggest minor elevation with extreme stress
      • Timing considerations: Blood draw is preferably done in the morning when test conditions are most standardized
      • Inform healthcare provider: Report recent illness, pregnancy status, medications, and any bone-related symptoms

How our test process works!

customers
customers